فلوفوكسامين (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "فلوفوكسامين" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place
11th place
86th place
1st place
1st place
5th place
4th place
43rd place
2nd place
6th place
3rd place
28th place
34th place
1,227th place
1,638th place

archive.org

cnn.com

edition.cnn.com

doi.org

  • Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
  • Schreiber S، Pick CG (أغسطس 2006). "From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram". European Neuropsychopharmacology. ج. 16 ع. 6: 464–8. DOI:10.1016/j.euroneuro.2005.11.013. PMID:16413173. S2CID:39278756.
  • Coquoz D، Porchet HC، Dayer P (سبتمبر 1993). "Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers". Clinical Pharmacology and Therapeutics. ج. 54 ع. 3: 339–44. DOI:10.1038/clpt.1993.156. PMID:8375130. S2CID:8229797.
  • Silver H (2001). "Fluvoxamine as an adjunctive agent in schizophrenia". CNS Drug Reviews. ج. 7 ع. 3: 283–304. DOI:10.1111/j.1527-3458.2001.tb00200.x. PMC:6741705. PMID:11607044.
  • Polcwiartek C، Nielsen J (مارس 2016). "The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review". Psychopharmacology. ج. 233 ع. 5: 741–50. DOI:10.1007/s00213-015-4161-1. PMID:26626327. S2CID:12168939.
  • Hashimoto، Kenji (مارس 2021). "Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor". European Archives of Psychiatry and Clinical Neuroscience. ج. 271 ع. 2: 249–258. DOI:10.1007/s00406-020-01231-x. ISSN:1433-8491. PMC:7785036. PMID:33403480. مؤرشف من الأصل في 2022-01-19.

inquirer.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
  • Kwasucki J، Stepień A، Maksymiuk G، Olbrych-Karpińska B (2002). "Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica – open trial". Wiadomosci Lekarskie. ج. 55 ع. 1–2: 42–50. PMID:12043315.
  • Schreiber S، Pick CG (أغسطس 2006). "From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram". European Neuropsychopharmacology. ج. 16 ع. 6: 464–8. DOI:10.1016/j.euroneuro.2005.11.013. PMID:16413173. S2CID:39278756.
  • Coquoz D، Porchet HC، Dayer P (سبتمبر 1993). "Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers". Clinical Pharmacology and Therapeutics. ج. 54 ع. 3: 339–44. DOI:10.1038/clpt.1993.156. PMID:8375130. S2CID:8229797.
  • Silver H (2001). "Fluvoxamine as an adjunctive agent in schizophrenia". CNS Drug Reviews. ج. 7 ع. 3: 283–304. DOI:10.1111/j.1527-3458.2001.tb00200.x. PMC:6741705. PMID:11607044.
  • Polcwiartek C، Nielsen J (مارس 2016). "The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review". Psychopharmacology. ج. 233 ع. 5: 741–50. DOI:10.1007/s00213-015-4161-1. PMID:26626327. S2CID:12168939.
  • Hashimoto، Kenji (مارس 2021). "Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor". European Archives of Psychiatry and Clinical Neuroscience. ج. 271 ع. 2: 249–258. DOI:10.1007/s00406-020-01231-x. ISSN:1433-8491. PMC:7785036. PMID:33403480. مؤرشف من الأصل في 2022-01-19.

ncbi.nlm.nih.gov

  • Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
  • Silver H (2001). "Fluvoxamine as an adjunctive agent in schizophrenia". CNS Drug Reviews. ج. 7 ع. 3: 283–304. DOI:10.1111/j.1527-3458.2001.tb00200.x. PMC:6741705. PMID:11607044.
  • Hashimoto، Kenji (مارس 2021). "Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor". European Archives of Psychiatry and Clinical Neuroscience. ج. 271 ع. 2: 249–258. DOI:10.1007/s00406-020-01231-x. ISSN:1433-8491. PMC:7785036. PMID:33403480. مؤرشف من الأصل في 2022-01-19.

pubchem.ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

web.archive.org

wikidata.org

  • Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
  • fluvoxamine (بالإنجليزية), QID:Q278487

worldcat.org

  • Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
  • Hashimoto، Kenji (مارس 2021). "Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor". European Archives of Psychiatry and Clinical Neuroscience. ج. 271 ع. 2: 249–258. DOI:10.1007/s00406-020-01231-x. ISSN:1433-8491. PMC:7785036. PMID:33403480. مؤرشف من الأصل في 2022-01-19.